Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Mallinckrodt plc (NYSE: MNK)

Mallinckrodt is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Areas of focus include therapeutic drugs for autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology and pulmonology along with analgesics and central nervous system drugs for prescribing by office- and hospital-based physicians. The company's core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines; its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing; and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has approximately 5,500 employees worldwide and a commercial presence in roughly 65 countries. The company's fiscal 2014 revenue totaled $2.54 billion. *

 

Period Start 2015-03-05 existent
  Group Mallinckrodt (Group)
Products Industry pharmaceutical
  Industry 2 contrast medium / imaging agent
Persons Person Trudeau, Mark (Mallinckrodt 201712 CEO)
  Person 2 Harbaugh, Matthew (Mallinckrodt 201712 CFO)
     
Region Region Dublin
  Country Ireland, Republic of
  City n. a. 
    Address record changed: 2020-12-02
     
Basic data Employees G: 5,001 to 10,000 (2015-03-05)
  Currency USD
  Annual sales 2,540,000,000 (revenue (fisacl year 2014))
     
    * Document for »About Section«: 
     
   
Record changed: 2023-07-10

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Mallinckrodt (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top